Category Archives: Cuban Medicine

New Cuban pharmaceuticals treat skin cancer

New Cuban pharmaceuticals presented
The prevalence of skin cancer in Cuba and the development of therapeutic injectibles to treat allergies caused by dust mites, were among issues discussed during several international conferences on dermatology and allergies, taking place in Havana’s International Conference Center, October 4-7

Author: Nuria Barbosa León | internet@granma.cu
october 6, 2017 14:10:40

Dr. Olaine Gray Lovio, recommends avoiding the sun during the hours of greatest intensity, between 10:00am and 5:00pm; wearing clothes of pastel colors that almost entirely cover the skin; using hats and parasols to protect the face; and applying sunscreen.

f0019263

 

 

 

 

 

 

 

Photo: Nuria Barbosa
The prevalence of skin cancer in Cuba and the development of therapeutic injectibles to treat allergies caused by dust mites, were among issues discussed during several international conferences on dermatology and allergies, taking place in Havana’s International Conference Center, October 4-7.

Dr. Olaine Gray Lovio explained to the press, prior to the events, that malignant growths on the skin are among the most prevalent cancers on the island, given the tropical climate and strong solar radiation during a large part of the day.

Every year in Cuba, approximately 8,000 cases of this disease, described as basal or squamous cell carcinoma or melanoma, are diagnosed, causing some 400 deaths. Emphasis is therefore being placed on reducing direct exposure to the sun’s ultraviolet rays, especially in the first 20 years of life.

Continue reading

Cuba registers new skin cancer medicine

Cuba registers new skin cancer medicine
Cuba has registered Genetic Engineering and Biotechnology Center (CIGB)a new skin cancer medicine called “Heberferon” developed by the island’s
Author: Cubadebate | internet@granma.cu
september 1, 2016 18:09:03

Skin Cancer

 

 

 

 

 

Photo: Cubadebate
After 20 years of research and clinical trials, Cuba’s Havana-based Genetic Engineering and Biotechnology Center (CIGB) has developed a new medicine called “Heberferon.”
BiologistIraldo Bello, who participated in the process, described the drug which combines interferón “Alfa” and interferón “Gamma” through the use of recombinant technology at the CIGB – as “unique” in the world. 
The injectable medication cures or reduces the size of malignant skin tumors and can prevent scaring from surgery in areas difficult to operate on such as the face, noted the specialist. 
Bello also explained that Cuba has a high rate of skin cancer, which is usually caused by excessive exposure to the sun.
CIGB production plants have already manufactured over 10,000 vials of the new medicine, which continues to be developed with the aim of treating other types of cancer. Meanwhile the next step will be to include Heberferon on the island’s list of basic medicines, he stated.
The CIGB also produces the complementary lung cancer medication “Cimavax EGF”, which is applied alongside conventional treatments such as radiation and chemotherapy, and despite not providing a cure, does help to manage the disease and improve the patient’s quality of life, above all, of those whose condition is in the advanced stage.
Another outstanding product developed by Cuba’s biotechnology and pharmaceutical industry is “Heberprot-P,” a medicine to treat diabetic foot ulcers and avoid amputations, as well as drugs against hepatitis B and meningitis.

Since February 26, 1962, to date, 85 million doses of polio vaccine have been administered in Cuba

Half a million infants to receive polio vaccine in upcoming campaign
Since 1962, 85 million doses of polio vaccine have been administered in Cuba, making the country the first in Latin America to eradicate the disease

Author: ACN | informacion@granma.cu
march 24, 2016 08:03:34

f0011417

 

 

 

 

 

 

 

Photo: Anabel Díaz

Since February 26, 1962, to date, 85 million doses of polio vaccine have been administered in Cuba, making the country the first in Latin America to eradicate this devastating childhood disease
The entire population under 68 years of age has been protected, according to Dr. Marlén Valcárcel, director of the Ministry of Public Health’s (Minsap) National Immunization Program, reported ACN, with children under three years of age being immunized initially as infants, plus a subsequent booster.
The doctor reported that during the second stage of the 55th national campaign, March 28 through April 3, a second dose of the vaccine will be administered orally to almost half a million children, 372,856 under the age of three.

Young Americans grateful for the opportunity to study medicine in Cuba

Young Americans grateful for the opportunity to study medicine in Cuba
Young people for the U.S. studying medicine in Havana welcomed news of the visit by President Obama to Cuba, and hope that the rapprochement between the two countries is mutually beneficial.

Author: Nuria Barbosa León | informacion@granma.cu
march 8, 2016 10:03:22

f0011057

 

 

 

 

 

ELAM students Shaneen Whyte, Patrick Daley and Jontay Darko. Photo: Orlando Perera (courtesy of ICAP)
Young people for the U.S. studying medicine in Havana welcomed news of the visit by President Obama to Cuba, and hope that the rapprochement between the two countries is mutually beneficial.

“I hope that during this visit March 21 and 22, there is an open and sincere dialogue, with agreements that are good for the two peoples,” Jontay Darko, a 5th year medical sciences student at the Salvador Allende Faculty in Havana, told Granma International. The faculty forms part of the Latin American School of Medicine (ELAM), which has graduated more than 24,000 health professionals from 84 countries, in its over 15 years of existence.

Continue reading

Cuba develops biopharmaceuticals to treat cancer

Cuba develops biopharmaceuticals to treat cancer
Cuba currently has a total of 28 drugs registered, or in various stages of investigation, for the treatment of cancer, which include therapeutic vaccines, monoclonal antibodies, interferons and peptides

Author: Orfilio Peláez | orfilio@granma.cu
february 4, 2016 09:02:03

f0010641

 

 

 

 

Photo: cubaahora.cu
Cuba currently has a total of 28 drugs registered, or in various stages of investigation, for the treatment of cancer, which include therapeutic vaccines, monoclonal antibodies, interferons and peptides, developed in different scientific institutions linked to the country’s biotechnology sector.

Dr. Rolando Pérez Rodríguez, of the Center of Molecular Immunology, reported on advances in the sector at the inauguration of the 5th International Seminar and National Workshop on Use and Development of Health Related Industrial Isotope Products, organized by the Center of Isotopes (Centis) and running through Friday, February 5, at Havana’s Hotel Riviera. Professionals from various countries, including Italy, Germany, the U.S., Hungary, Spain, Brazil, the Dominican Republic, Honduras and El Salvador are participating in the event.

As the specialist noted, these biopharmaceuticals should have an increasing impact over the coming years in cancer treatment, with the aim of turning advanced cancer into a long-term manageable chronic disease, with an acceptable quality of life.

He also highlighted that the planned introduction in the country of advanced imaging equipment in nuclear medicine and oncology will lead to more effective treatment for malignant neoplasms, according to the specific biological characteristics of each tumor.

Also speaking at the opening of the event, Dr. Jorge Cruz Arencibia, director of Centis, noted that beyond import substitution, the gradual installation of a plant to produce yttrium-90 will enhance the use of therapeutic radiopharmaceuticals in the treatment of neuroendocrine tumors, joint complications due to rheumatoid arthritis and hemophilia, pain relief for bone metastases, non-Hodgkin lymphoma, and other types of tumors.

Cuban hepatitis B medication undergoing clinical trials

Cuban hepatitis B medication undergoing clinical trials
A Cuban medication to treat chronic hepatitis B, HeberNasvac, created by scientists at the Genetic Engineering and Biotechnology Center (CIGB), is currently undergoing clinical trials in collaboration with the French company Abivax

Author: Prensa Latina | internet@granma.cu
august 11, 2015 17:08:49

A Cuban medication to treat chronic hepatitis B, HeberNasvac, created by scientists at the Genetic Engineering and Biotechnology Center (CIGB), is currently undergoing clinical trials in collaboration with the French company Abivax.

f0008151

 

 

 

 

 

PHOTO: www.radiohc.cu

A Cuban medication to treat chronic hepatitis B, HeberNasvac, created by scientists at the Genetic Engineering and Biotechnology Center (CIGB), is currently undergoing clinical trials in collaboration with the French company Abivax.

The product has been undergoing safety and efficacy tests for several years, stated a CIGB specialist.

According to Iris Lugo Carro, the clinical trials being carried out by Cuban scientists and Abivax – involving 230 patients from eight Asian countries, and the participation of 50 clinical centers – are being realized under regulation ABX 203.

Continue reading

Cuba removed from list of state sponsors of terrorism, one step in the right direction

Cuba removed from list of state sponsors of terrorism
of Terrorism designation, effective today, May 29 The U.S. Secretary of State John Kerry signed the final order to rescind Cuba’s State Sponsor

th-3

 

 

 

 

Author: Prensa Latina(PL) | internet@granma.cu
may 29, 2015 13:05:44
Washington, May 29; a Press Statement by U.S. State Department spokesman, Jeff Rathke, informed of Cuba’s official removal from the list of state sponsors of terrorism.
In the official statement, the State Department spokesman noted that “The 45-day Congressional pre-notification period has expired, and the Secretary of State has made the final decision to rescind Cuba’s designation as a State Sponsor of Terrorism, effective today, May 29, 2015.”

Cuba has been included on the unilateral list drawn up by Washington since 1982.
In the statement he also noted that the “While the United States has significant concerns and disagreements with a wide range of Cuba’s policies and actions, these fall outside the criteria relevant to the rescission of a State Sponsor of Terrorism designation.”
In order to come into effect, the decision must be published in the Federal Register (the daily newspaper of the Federal government), although the diplomatic office has assured that the decision is effective immediately.

 

 

Life expectancy: 78.45 years
The provinces of Las Tunas and Holguín have a life expectancy of approximately 79.5 years, the highest in the country
Author: Orfilio Peláez | orfilio@granma.cu
may 26, 2015 09:05:47

f0007443

 

 

 

 

 

A rise in the life expectancy of both sexes was recorded in all provinces. Photo: Yaimí Ravelo

At the end of the period 2011-2013, the Cuban population’s life expectancy was 78.45 years, placing the island among the top 25 nations registering the highest figure in this human development indicator.

Juan Carlos Alfonso Fraga MSc. director of the National Office of Statistics and Information’s (ONEI) Center for Population and Development Studies (Cepde), stated to Granma that the cited figure represents a 0.48 increase in comparison to the period 2005-2007, which registered an average of 77.97 years. A rise in the life expectancy of both sexes was recorded in all provinces.
Specifically, the life expectancy of Cuban women is 80.45 years, while it is 76.50 for men. On average, the citizens of Las Tunas, Holguin, Villa Clara and Guantánamo, surpass 81 years; while those born in Artemisa, Camagüey, Havana and Mayabeque fail to reach the age of 80.

 

WHO Director General Thanks Cuba For Giving The Ebola Crisis So Many Highly Experience Doctors

 

1ch_0

WHO Director General Sends Message to ALBA-TCP Extraordinary Summit on Ebola

Submitted by editor on Mon, 10/20/2014 – 00:00

 

Greetings from the World Health Organization in Geneva.

I must begin by thanking the Cuban government for giving the Ebola outbreak response so many highly experienced Cuban doctors and nurses. I have seen the many news photographs of these staff in their sparkling white lab jackets, ready to help. This brings a most welcome face of hope to what is otherwise a horrific outbreak.

I welcome this opportunity to address members of the Bolivarian Alliance. I welcome the purpose of this meeting: you are absolutely doing the right thing. You want to step up your level of preparedness for an imported Ebola case on the most urgent basis possible. WHO working with PAHO are here to support you in any way we can.

Continue reading